Search Results
Sep 17, 2025, 16:02 ET City of Santa Fe Chooses OpenGov to Digitize Permitting & Licensing Experience
Lamboy, Director of Planning & Land Use for the City of Santa Fe. "OpenGov will let us be efficient, transparent, and modernize land use in Santa Fe, finally meeting the expectations of residents and developers." Earlier this year,
More news about: OpenGov, Inc.
Sep 17, 2025, 09:01 ET Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall
Albuquerque, Santa Fe and surrounding areas. Locally owned and family-operated, Nespolo is committed to keeping New Mexico homes comfortable
More news about: Nespolo Mechanical
Sep 17, 2025, 08:47 ET Frame Bio Licenses Novel Drug Delivery Technology from Mercury Bio to Develop Regenerative Therapies for Bone and Collagen Diseases and Disorders
SANTA FE, N.M., Sept. 17, 2025 /PRNewswire/ --
More news about: Frame Bio LLC
Sep 17, 2025, 08:00 ET Study Published in the Journal Infection Demonstrates Clinical Utility of SeptiCyte® RAPID to Diagnose Sepsis in Critically Ill Patients with Hospital Acquired Infections
detecting sepsis in critically ill patients with nosocomial infections," commented Paula Ramírez Galleymore, MD, Hospital Universitario y Politécnico de la Fe and Former President of the Scientific Committee of the Spanish Society of Intensive Care, Critical Care and Coronary Care Units (SEMICYUC). "Notably,
More news about: Immunexpress, Inc.
Sep 16, 2025, 16:44 ET Minno lanza Guillermo & Will, una serie de títeres bilingüe única en su clase, que lleva el amor de Dios a los niños en inglés y español
"Durante más de 75 años, Family Theater Productions ha creado medios para ayudar a las familias a crecer en la fe. Guillermo & Will continúa ese legado, ofreciendo relatos alegres y llenos de fe para niños, con especial atención a familias, incluyendo a audiencias católicas y de habla hispana, que
More news about: Minno
Sep 16, 2025, 10:15 ET Philatron Wire & Cable to Showcase Mission-Grade Data Center Power Solutions at POWER 2025, Booth #605
SANTA FE SPRINGS, Calif., Sept. 16, 2025 /PRNewswire/ --
More news about: Philatron International
Sep 16, 2025, 08:35 ET Metallium Enters into Binding Collaboration with Ucore Rare Metals to Integrate Metallium's Flash Joule Heating Technology with Ucore's RapidSX™ Rare Earths Elements Separation Technology
REE-bearing feedstocks into enriched mixed rare earth chlorides or EMRECs, selectively remove deleterious elements and apply FHJ as a pre-treatment for high-Fe/Al feedstocks to enable their acceptance in downstream systems. Metallium and Ucore will also investigate the recovery of highly strategic heavy
More news about: MTM Critical Metals Ltd.
Sep 16, 2025, 03:00 ET Muxía, o marco zero do 'Prestige', regressa aos holofotes internacionais pelas suas famosas pedras
do Caminho Luso-Galego Mariano, cada vez mais peregrinos estão a cronometrar a sua chegada para coincidir com este dia místico, partilhando, seja por fé ou simples tradição, um desejo comum de melhor saúde. Muxía, conhecida como "a noiva do vento", agora aguarda mais peregrinos e o reconhecimento
More news about: Muxía
Sep 15, 2025, 06:00 ET Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias
CEO of Gyala Therapeutics, added: "Our next goal is to launch a clinical trial of GYA01 in AML patients at Hospital Clinic Barcelona and Hospital La Fe in Valencia, bringing this therapy to patients with aggressive leukemias who lack alternatives." The program
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias
CEO of Gyala Therapeutics, added: "Our next goal is to launch a clinical trial of GYA01 in AML patients at Hospital Clinic Barcelona and Hospital La Fe in Valencia, bringing this therapy to patients with aggressive leukemias who lack alternatives." The program
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics stellt erste CAR-T-Therapie ihrer Klasse vor, die auf CD84 abzielt und eine starke präklinische Wirksamkeit bei schwer zu behandelnden Leukämien zeigt.
Therapeutics, fügte hinzu: „Unser nächstes Ziel ist es, eine klinische Studie mit GYA01 bei AML-Patienten im Hospital Clinic Barcelona und im Hospital La Fe in Valencia zu starten, um diese Therapie Patienten mit aggressiven Leukämien zugänglich zu machen, für die es keine
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics dévoile la première thérapie CAR-T de sa catégorie ciblant CD84, qui montre une forte efficacité préclinique dans les leucémies difficiles à traiter
Notre prochain objectif est de lancer un essai clinique pour GYA01 sur des patients atteints de LMA à l'Hospital Clinic Barcelona et à l'Hospital La Fe à Valencia, afin d'offrir cette thérapie aux patients atteints de leucémies agressives qui n'ont pas d'autres solutions
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics presenta la primera terapia CAR-T de su clase
ensayo clínico con GYA01 en pacientes con leucemia mieloide aguda en el Hospital Clínic de Barcelona y el Hospital La Fe de Valencia, para ofrecer esta terapia a pacientes con leucemias agresivas que no tienen otras alternativas". El
More news about: Gyala Therapeutics